Your browser is no longer supported. Please, upgrade your browser.
Settings
REPH Recro Pharma, Inc. daily Stock Chart
REPH [NASD]
Recro Pharma, Inc.
Index- P/E- EPS (ttm)-3.83 Insider Own1.30% Shs Outstand21.65M Perf Week-1.55%
Market Cap178.40M Forward P/E36.62 EPS next Y0.23 Insider Trans0.00% Shs Float20.65M Perf Month-14.17%
Income-79.70M PEG- EPS next Q-1.06 Inst Own70.10% Short Float4.60% Perf Quarter3.13%
Sales77.30M P/S2.31 EPS this Y-76.10% Inst Trans0.07% Short Ratio2.15 Perf Half Y13.81%
Book/sh-0.91 P/B- EPS next Y112.90% ROA-46.20% Target Price11.20 Perf Year-28.35%
Cash/sh1.78 P/C4.63 EPS next 5Y- ROE-739.70% 52W Range4.78 - 13.05 Perf YTD16.06%
Dividend- P/FCF- EPS past 5Y-54.30% ROI-159.90% 52W High-36.86% Beta-0.25
Dividend %- Quick Ratio2.10 Sales past 5Y- Gross Margin44.20% 52W Low72.38% ATR0.53
Employees255 Current Ratio2.50 Sales Q/Q-6.30% Oper. Margin-69.90% RSI (14)52.94 Volatility4.60% 5.99%
OptionableYes Debt/Eq- EPS Q/Q-127.10% Profit Margin- Rel Volume0.43 Prev Close8.36
ShortableYes LT Debt/Eq- EarningsMay 21 BMO Payout- Avg Volume442.51K Price8.24
Recom1.80 SMA209.21% SMA50-1.23% SMA20013.85% Volume190,618 Change-1.44%
Jan-31-19Resumed Janney Buy $13
Feb-14-18Initiated Oppenheimer Outperform $19
Dec-19-16Initiated Piper Jaffray Overweight $12
Nov-14-16Initiated Aegis Capital Buy $21
Oct-03-16Resumed Brean Capital Buy
Sep-16-16Initiated ROTH Capital Buy
Nov-24-15Resumed H.C. Wainwright Buy $14
Sep-02-15Initiated H.C. Wainwright Buy $19
Jun-18-15Reiterated Brean Capital Buy $26 → $28
Apr-14-15Reiterated MLV & Co Buy $12 → $22
Jun-12-14Initiated Aegis Capital Buy $40
Mar-20-14Initiated Brean Capital Buy $26
Apr-16-19 07:00AM  Recro Pharma Announces Six-Year Extension of License and Supply Agreement Between Teva and Recro Gainesville GlobeNewswire
Apr-11-19 04:05PM  Recro Pharma Announces Presentation of New Meta-Analysis for IV Meloxicam at the 44th Annual Regional Anesthesiology and Acute Pain Medicine Meeting GlobeNewswire
Apr-04-19 10:58AM  Recro Pharma eliminates 50 jobs following FDA setback American City Business Journals +27.91%
07:58AM  The Daily Biotech Pulse: Recro Restructures, Biotechs Raise Proceeds In Droves, Silk Road, NGM Biopharma To Debut Benzinga
Apr-03-19 04:05PM  Recro Pharma Restructures Acute Care Segment While Continuing To Execute on Strong CDMO Segment Performance GlobeNewswire
Mar-26-19 11:51AM  Recro Pharma Falls as FDA Denies Approval to Pain Candidate Zacks
Mar-25-19 04:29PM  Why Recro Pharma's stock price plunged more than 34% today American City Business Journals -34.04%
10:53AM  More Pain For Recro Pharma: FDA Rejects Meloxicam NDA For Second Time Benzinga
07:45AM  Recro Pharma's stock plunges to pace premarket decliners after 2nd CRL for pain treatment MarketWatch
07:00AM  Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors GlobeNewswire
Mar-22-19 04:33PM  FDA rejects Malvern pharma firm's non-opioid pain killer for a second time American City Business Journals
03:30PM  Recro Pharma Receives Complete Response Letter from the FDA for Intravenous Meloxicam GlobeNewswire
Mar-12-19 07:00AM  Recro Pharma to Host Educational Symposium on Pain Management Options in Total Joint Replacements at the American Academy of Orthopaedic Surgeons 2019 Annual Meeting GlobeNewswire
Mar-05-19 09:00AM  Options Traders Expect Huge Moves in Recro Pharma (REPH) Stock Zacks
Mar-04-19 07:00AM  Recro Pharma Obtains $40.5 Million of Non-Dilutive Capital Through Expanded Credit Facility GlobeNewswire
Feb-25-19 04:05PM  Recro Pharma Announces Publication of Phase III IV Meloxicam Clinical Safety and Opioid Use Data in the Journal Clinical Pharmacology in Drug Development GlobeNewswire
Feb-21-19 11:59AM  Edited Transcript of REPH earnings conference call or presentation 19-Feb-19 1:00pm GMT Thomson Reuters StreetEvents
Feb-20-19 07:00AM  Recro Pharma Announces New IV Meloxicam Data Publication in the Journal Regional Anesthesia & Pain Medicine GlobeNewswire
Feb-19-19 07:24AM  Recro Pharma: 4Q Earnings Snapshot Associated Press
07:00AM  Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018 GlobeNewswire
06:00AM  Recro Pharma, Inc. to Host Earnings Call ACCESSWIRE
Feb-15-19 04:08PM  What's in the Cards for Bausch Health (BHC) Q4 Earnings? Zacks
Feb-14-19 12:58PM  5 Drug/Biotech Stocks Set to Beat Estimates in Q4 Earnings Zacks
07:00AM  Recro Pharma to Report Fourth Quarter and Year End 2018 Financial Results and Host Conference Call and Webcast on February 19, 2019 GlobeNewswire
Feb-11-19 07:00AM  Recro Pharma Announces Five-Year Manufacturing and Supply Agreement Between Novartis and Recro Gainesville GlobeNewswire +5.43%
Jan-30-19 01:10PM  Could Recro Pharma, Inc.s (NASDAQ:REPH) Investor Composition Influence The Stock Price? Simply Wall St.
Jan-23-19 08:11AM  5 Domestic Stocks to Gain From Thaw in Trade Talks Zacks
Jan-02-19 07:00AM  Recro Pharma Amends Athyrium Credit Facility GlobeNewswire
Dec-21-18 11:32AM  Recro Pharma restructures licensing agreement for non-opioid pain medicine American City Business Journals
07:00AM  Recro Pharma Amends IV Meloxicam License Agreement with Alkermes GlobeNewswire
Dec-10-18 07:00AM  Recro Pharma Announces Presentation of New Data Demonstrating IV Meloxicams Effect on Platelet Function at the 72nd PostGraduate Assembly in Anesthesiology GlobeNewswire
Nov-27-18 01:23PM  Our Take On Recro Pharma Incs (NASDAQ:REPH) CEO Salary Simply Wall St.
Nov-20-18 09:52AM  Edited Transcript of REPH earnings conference call or presentation 7-Nov-18 1:00pm GMT Thomson Reuters StreetEvents
Nov-16-18 08:20AM  Detailed Research: Economic Perspectives on StarTek, Plantronics, Akoustis Technologies, Genie Energy, Recro Pharma, and BIO-key International What Drives Growth in Today's Competitive Landscape GlobeNewswire
Nov-14-18 07:00AM  Recro Pharma Announces Publication of Phase II IV Meloxicam Abdominal Hysterectomy Data in Anesthesia & Analgesia GlobeNewswire
Nov-08-18 07:00AM  Recro Pharma to Participate in Upcoming Investor Conferences GlobeNewswire
Nov-07-18 11:00AM  Recro Pharma (REPH) Reports Q3 Loss, Tops Revenue Estimates Zacks
10:44AM  Recro Pharma: 3Q Earnings Snapshot Associated Press
07:00AM  Recro Pharma Reports Third Quarter 2018 Financial Results Raising Guidance for CDMO business for 2018 GlobeNewswire
Oct-31-18 07:00AM  Recro Pharma to Report Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018 GlobeNewswire
Oct-09-18 04:19PM  FDA Sets Action Date for Recro's Pain Management Candidate Zacks
Oct-08-18 12:00PM  Take two: Recro tries for second time to get FDA approval for its non-opioid pain medicine American City Business Journals
07:00AM  Recro Pharma Announces PDUFA Date for IV Meloxicam GlobeNewswire
Oct-01-18 07:00AM  Recro Announces Expansion of CDMO Service Capabilities GlobeNewswire
Sep-10-18 07:00AM  Recro Pharma to Participate in Upcoming Investor Conferences GlobeNewswire
Sep-05-18 07:00AM  Recro Pharma to Present IV Meloxicam Data at PAINWeek® 2018 GlobeNewswire +11.77%
Sep-04-18 10:50AM  Recro Pharma to resubmit application for non-opioid pain medicine American City Business Journals +26.49%
09:30AM  3 Stocks to Watch As The Healthcare Sector Heats Up ACCESSWIRE
07:00AM  Recro Pharma Provides Regulatory Update for IV Meloxicam GlobeNewswire
Aug-20-18 09:46PM  Edited Transcript of REPH earnings conference call or presentation 7-Aug-18 12:00pm GMT Thomson Reuters StreetEvents
Aug-07-18 10:40AM  Recro Pharma (REPH) Reports Q2 Loss, Tops Revenue Estimates Zacks
09:33AM  Recro Pharma: 2Q Earnings Snapshot Associated Press
07:00AM  Recro Pharma Reports Second Quarter 2018 Financial Results GlobeNewswire
06:00AM  Recro Pharma, Inc. to Host Earnings Call ACCESSWIRE
Aug-06-18 03:39PM  Recro Pharma Q2 Earnings Preview Benzinga
Jul-31-18 07:00AM  Recro Pharma to Report Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 7, 2018 GlobeNewswire
Jul-30-18 11:19AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TAL, QCOM, REVG, FLKS and REPH GlobeNewswire
10:42AM  FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses Exceeding $50K of Class Action Against Recro Pharma, Inc. (REPH) & Lead Plaintiff Deadline: July 30, 2018 ACCESSWIRE
Jul-29-18 11:00AM  SHAREHOLDER ALERT: TAL ORA REVG FPI NWL PCG REPH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Jul-27-18 08:55PM  Glancy Prongay & Murray LLP Reminds Investors of Lead Plaintiff Deadline in the Class Action Lawsuit Against Recro Pharma, Inc. (REPH) GlobeNewswire
02:41PM  CLASS ACTION UPDATE for ORA and REPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
12:55PM  3-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE
10:38AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses Exceeding $50K of Class Action Against Recro Pharma, Inc. (REPH) & Lead Plaintiff Deadline: July 30, 2018 ACCESSWIRE
Jul-26-18 03:13PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MRCY, REVG and REPH GlobeNewswire
01:27PM  MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
Jul-25-18 04:45PM  CLASS ACTION UPDATE for FIZZ, ACAD and REPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
04:40PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Recro Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline - REPH ACCESSWIRE
02:10PM  5-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE
11:57AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TAL, ANW, DB, FIZZ and REPH GlobeNewswire
10:37AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Recro Pharma, Inc. (REPH) & Lead Plaintiff Deadline - July 30, 2018 ACCESSWIRE
Jul-24-18 04:00PM  CLASS ACTION UPDATE for QCOM, FLR, FPI and REPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
01:50PM  JULY 30 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
11:00AM  SHAREHOLDER ALERT: ATEN ANW DB QCOM FPI FIZZ SBGL ACAD FLR REPH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Jul-23-18 06:43PM  The Law Offices of Howard G. Smith Reminds Investors of July 30th Deadline in the Class Action Lawsuit Against Recro Pharma, Inc. (REPH) Business Wire
02:30PM  DEADLINE ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:57PM  CLASS ACTION UPDATE for ATEN, FLR and REPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
01:22PM  Important Stockholder Deadline Alert in Class Action Lawsuit Filed Against Recro Pharma, Inc. by Kaskela Law LLC GlobeNewswire
12:35PM  NOTICE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Recro Pharma, Inc.- REPH ACCESSWIRE
12:15PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ORA, REPH, FLR, FIZZ, NWL and PCG GlobeNewswire
10:24AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Recro Pharma, Inc. (REPH) & Lead Plaintiff Deadline - July 30, 2018 ACCESSWIRE
Jul-22-18 05:20PM  CLASS ACTION UPDATE for QCOM, REPH and PCG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Jul-20-18 05:10PM  CLASS ACTION UPDATE for COOL, REPH and SBGL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
02:30PM  DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Jul-19-18 01:00PM  SHAREHOLDER ALERT MFGP ATEN REPH DB QCOM TAL NWL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire +5.15%
10:30AM  REPH EQUITY NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Recro Pharma, Inc.; Upcoming Deadline- REPH PR Newswire
07:05AM  Free Technical Reports on Portola Pharma and Three Additional Biotech Equities ACCESSWIRE
Jul-18-18 04:08PM  CLASS ACTION UPDATE for MFGP REPH and HAIR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
03:25PM  INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
02:47PM  UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of REPH, ANW, DB and QCOM GlobeNewswire
02:30PM  Recro Pharma, Inc. Alert: Pawar Reminds of Important July 30, 2018 Lead Plaintiff Deadline in Class Action - REPH ACCESSWIRE
01:14PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Recro Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline REPH GlobeNewswire
Jul-17-18 11:14AM  SHAREHOLDER ALERT PPG ATEN REPH REVG UNM HAIR GOGO COOL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Jul-16-18 05:35PM  DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
05:11PM  CLASS ACTION UPDATE for PPG and REPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:18AM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Recro Pharma, Inc. (REPH) & Lead Plaintiff Deadline July 30, 2018 ACCESSWIRE
Jul-15-18 12:00AM  SHAREHOLDER ALERT PRTA SYMC PPG MFGP FLR ATEN REPH DB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Jul-14-18 08:43AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Recro Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline - REPH ACCESSWIRE
Jul-13-18 12:53PM  SHAREHOLDER ALERT HAIR GOGO COOL MD GLCNF GLNCY ATEN REPH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Jul-12-18 04:04PM  UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SYMC, MFGP, FLR, REPH, and ORA GlobeNewswire
03:20PM  DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Recro Pharma, Inc., a specialty pharmaceutical company, develops and commercializes products for hospital and related acute care settings. The company operates in two segments, Acute Care, and Contract Development and Manufacturing. Its lead product candidate includes injectable meloxicam, which completed pivotal phase III clinical trials for the treatment of post-operative pain. The company also develops early-stage product candidates, which include Dex-IN, an intranasal formulation of dexmedetomidine for use in clinical sedation; and two novel neuromuscular blocking agents and a related proprietary chemical reversal agent. In addition, it provides formulation and development services to develop and manufacture pharmaceutical products using proprietary delivery technologies and know-how for commercial partners. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was founded in 2007 and is based in Malvern, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Broadfin Healthcare Master Fun10% OwnerMay 24Sale5.81188,0001,093,1822,048,025May 24 05:02 PM